Patent application number | Description | Published |
20080249149 | Crystalline Forms of Rizatriptan Benzoate - The present invention is directed to the novel polymorphic Form A and Form B of Rizatriptan benzoate, processes for the preparation thereof and pharmaceutical compositions comprising these crystalline forms. | 10-09-2008 |
20090057613 | FLUORESCENT QUINACRIDONES - The present invention relates to compounds of the Formula (I), a process for their preparation and their use for the preparation of inks, colorants, pigmented plastics, coatings, non-impact-printing material, color filters, cosmetics, polymeric ink particles, toners, as fluorescent tracers, in color changing media, in solid dye lasers and electroluminescent devices. A luminescent device comprising a composition according to the present invention is high in the efficiency of electrical energy utilisation and high in luminance. | 03-05-2009 |
20090062560 | Electroluminescent Metal Complexes With Triazoles - Disclosed are electroluminescent metal complexes with triazoles of the formula (I), where n1 is an integer of 1 to 3, m1 and m2 each are an integer 0, 1 or 2, M | 03-05-2009 |
20100003520 | POROUS INORGANIC MATERIALS OF SILCON AND OXYGEN - The present invention relates to a process for the production of porous inorganic materials or a matrix material containing nanoparticles with high uniformity of thickness and/or high effective surface area and to the materials obtainable by this process. By the above-mentioned process materials with a defined thickness in the region of ±10%, preferably ±5% of the average thickness are available. | 01-07-2010 |
20100249349 | Novel Polymers - The present invention relates to novel polymers comprising a repeating unit of the formula (I) and their use in electronic devices. The polymers according to the invention have excellent solubility in organic solvents and excellent film-forming properties. In addition, high charge carrier mobilities and high stability of the emission color can be observed, if the polymers according to the invention are used in organic light emitting diodes (OLEDs). | 09-30-2010 |
20110086454 | DIBENZOFURANE POLYMERS FOR ELECTROLUMINISCENT DEVICES - Disclosed are electroluminescent materials comprising a homopolymer based on recurring structural units of the formula (I) | 04-14-2011 |
20110159050 | AMPHIPHILIC PROTEINS AS MORPHOLOGY MODIFIERS - Disclosed is a process for modifying the morphology and/or polymorphism of an organic substance, which process comprises treating the solid substance, or a solution or dispersion thereof, with one or more amphiphilic proteins. | 06-30-2011 |
20120101126 | CRYSTALLINE FORMS OF PITAVASTATIN CALCIUM - The present invention is directed to new crystalline forms of Pitavastatin hemicalcium salt, referred to hereinafter as polymorphic Forms A, B, C, D, E and F, as well as the amorphous form. Furthermore, the present invention is directed to processes for the preparation of these crystalline forms and the amorphous form and pharmaceutical compositions comprising these crystalline forms or the amorphous form. | 04-26-2012 |
20120128611 | UV FILTER COMBINATIONS COMPRISING BENZYLIDENE MALONATES - Disclosed is the use of a UV filter combination, comprising (a) a first UV filter selected from benzylidene malonates of formula (1), wherein R | 05-24-2012 |
20130053413 | CRYSTALLINE FORMS OF PITAVASTATIN CALCIUM - The present invention is directed to new crystalline forms of Pitavastatin hemicalcium salt, referred to hereinafter as polymorphic Forms A, B, C, D, E and F, as well as the amorphous form. Furthermore, the present invention is directed to processes for the preparation of these crystalline forms and the amorphous form and pharmaceutical compositions comprising these crystalline forms or the amorphous forms. | 02-28-2013 |
20130292660 | ELECTROLUMINESCENT METAL COMPLEXES WITH NUCLEOPHILIC CARBENE LIGANDS - This invention relates to electroluminescent metal complexes of the formula (I) | 11-07-2013 |
20140005402 | CRYSTALLINE FORMS OF PITAVASTATIN CALCIUM | 01-02-2014 |
20140364614 | CRYSTALLINE FORMS OF PITAVASTATIN CALCIUM - The present invention is directed to new crystalline forms of Pitavastatin hemicalcium salt, referred to hereinafter as polymorphic Forms A, B, C, D, E and F, as well as the amorphous form. Furthermore, the present invention is directed to processes for the preparation of these crystalline forms and the amorphous form and pharmaceutical compositions comprising these crystalline forms or the amorphous forms. | 12-11-2014 |